Eugene Moylan
Impact in
Papers in
- Oncology 16
- Cancer Treatment and Pharmacology 7
- Colorectal Cancer Treatments and Studies 3
- Cancer Immunotherapy and Biomarkers 2
- HER2/EGFR in Cancer Research 2
- Inflammatory Biomarkers in Disease Prognosis 2
-
- Advanced Breast Cancer Therapies 4
- Co-authors
- Séamus O’Reilly (9 shared papers)Min Yuen Teo (2 shared papers)Catherine Keohane (2 shared papers)Susan Murray (2 shared papers)Richard Bambury (4 shared papers)Stuart A. Grossman (1 shared paper)Catherine Drake (4 shared papers)Niamh Bermingham (2 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Integrative Cancer Therapies (2 papers)Cancer Nursing (1 paper)The Medical Journal of Australia (1 paper)Clinical Oncology (1 paper)
- Partner nations
- AustraliaIrelandUnited States
In The Last Decade
Eugene Moylan
30 papers receiving 547 citations
Peers
Comparison fields: 5 of 67
- Oncology 281
- Genetics 91
- Immunology 85
- Applied Psychology 17
- Cancer Research 39
Countries citing papers authored by Eugene Moylan
This map shows the geographic impact of Eugene Moylan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene Moylan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene Moylan more than expected).
Fields of papers citing papers by Eugene Moylan
This network shows the impact of papers produced by Eugene Moylan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene Moylan. The network helps show where Eugene Moylan may publish in the future.
Co-authors
The 25 scholars most cited alongside Eugene Moylan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 186 | |
| 2 | 2002 | 159 | |
| 3 | 2015 | 32 | |
| 4 | 2005 | 23 | |
| 5 | 2009 | 19 | |
| 6 | 2022 | 15 | |
| 7 | 2000 | 14 | |
| 8 | 2016 | 13 | |
| 9 | 2019 | 12 | |
| 10 | 2002 | 10 | |
| 11 | 2011 | 10 | |
| 12 | 2001 | 10 | |
| 13 | 2007 | 8 | |
| 14 | 2005 | 8 | |
| 15 | 2009 | 6 | |
| 16 | 1997 | 5 | |
| 17 | 2004 | 4 | |
| 18 | 2017 | 3 | |
| 19 | 2020 | 3 | |
| 20 | 2006 | 2 |
About Eugene Moylan
Eugene Moylan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Surgery, having authored 35 papers that have together received 558 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (6 papers), Advanced Breast Cancer Therapies (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), HER2/EGFR in Cancer Research (2 papers), Economic and Financial Impacts of Cancer (2 papers) and Inflammatory Biomarkers in Disease Prognosis (2 papers). The work is most often cited by research in Oncology (281 citations), Genetics (91 citations), Immunology (85 citations), Applied Psychology (17 citations) and Cancer Research (39 citations). Eugene Moylan has collaborated with scholars based in Australia, Ireland and United States. Frequent co-authors include Séamus O’Reilly, Min Yuen Teo, Catherine Keohane, Susan Murray, Richard Bambury, Stuart A. Grossman, Catherine Drake, Niamh Bermingham, Torben Skovsgaard and John R.T. Monson. Their work appears in journals such as Journal of Clinical Oncology, Integrative Cancer Therapies, Cancer Nursing, The Medical Journal of Australia and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.